Internal Medicine, Pulmonary Disease · Little River, SC
NPI
1639175516
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3980 Highway 9 E, Suite 340
Little River, SC, 29566
Phone (843) 390-8302
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
1,603 services
Medicare patients, 2024
692
Average age 75
Drug cost, 2024
$2.1M
2,554 prescriptions
Company payments, 2025
$1,959
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin M Dineen was code 99214 (office e&m - established), 293 times for 277 patients. In total Kevin M Dineen billed 1,603 services in 40 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 293 | 277 | $83.23 | $24K |
| 99291 Critical Care E&M | Facility | 161 | 65 | $155.68 | $25K |
| 99204 Office E&M - New | Office | 131 | 131 | $110.63 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 62 | $86.88 | $9,731 |
| 94727 Pulmonary Function Testing | Office | 104 | 104 | $31.95 | $3,323 |
| 94729 Pulmonary Function Testing | Office | 99 | 99 | $39.62 | $3,922 |
| 94060 Pulmonary Function Testing | Office | 93 | 93 | $27.37 | $2,545 |
| 99215 Office E&M - Established | Office | 58 | 55 | $119.62 | $6,938 |
| 99223 Hospital E&M - Initial | Facility | 53 | 53 | $126.88 | $6,725 |
| 31624 Bronchoscopy | Facility | 47 | 47 | $40.35 | $1,896 |
| 94727 Pulmonary Function Testing | Facility | 44 | 44 | $8.49 | $373 |
| 94729 Pulmonary Function Testing | Facility | 44 | 44 | $6.30 | $277 |
| 94060 Pulmonary Function Testing | Facility | 44 | 44 | $7.26 | $319 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 21 | $58.97 | $1,946 |
| 31629 Bronchoscopy | Facility | 32 | 30 | $128.93 | $4,126 |
By year: 2022 $125K for 1,460 services; 2023 $131K for 1,618 services; 2024 $121K for 1,603 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin M Dineen prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 503 prescriptions and refills. In total Kevin M Dineen wrote 2,554 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 503 | 894 | 129 | $562K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 421 | 611 | 142 | $15K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 180 | 256 | 45 | $117K |
| Breo Ellipta Fluticasone/Vilanterol | 138 | 210 | 38 | $81K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 121 | 195 | 25 | $91K |
| Azithromycin Generic | 117 | 247 | 35 | $3,238 |
| Ethambutol Hcl Generic | 97 | 223 | 33 | $5,919 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 94 | 148 | 26 | $92K |
| Rifampin Generic | 83 | 177 | 27 | $5,873 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 56 | 85 | 19 | $7,685 |
| Omeprazole Generic | 47 | 132 | 19 | $726 |
| Spiriva Respimat Tiotropium Bromide | 40 | 76 | 13 | $39K |
| Montelukast Sodium Generic | 40 | 106 | 14 | $489 |
| Symbicort Budesonide/Formoterol Fumarate | 39 | 73 | 13 | $16K |
| Prednisone Generic | 34 | 38 | 22 | $138 |
Brand drugs: 1,694 claims; generic drugs: 860 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin M Dineen $1,959 ($1,959 in general payments such as food, travel and fees) from 18 companies. The largest payer was Verona Pharma, Inc. with $266.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 7 | $266 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $251 |
| Genzyme Corporation SNY | 7 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $206 |
| United Therapeutics Corporation UTHR | 6 | $183 |
| GlaxoSmithKline, LLC. GSK | 10 | $180 |
| Insmed, Inc. INSM | 5 | $143 |
| Grifols USA, LLC | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $88.03 |
| Merck Sharp & Dohme LLC MRK | 4 | $86.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.